Maropitant

CAS No. 147116-67-4

Maropitant ( —— )

Catalog No. M20648 CAS No. 147116-67-4

Maropitant is a selective neurokinin (NK1) receptor antagonist.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 39 In Stock
5MG 65 In Stock
10MG 110 In Stock
25MG 177 In Stock
50MG 335 In Stock
100MG 500 In Stock
500MG 1098 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Maropitant
  • Note
    Research use only not for human use.
  • Brief Description
    Maropitant is a selective neurokinin (NK1) receptor antagonist.
  • Description
    Maropitant is a selective neurokinin (NK1) receptor antagonist.
  • Synonyms
    ——
  • Pathway
    GPCR/G Protein
  • Target
    Neurokinin Receptor
  • Recptor
    NK1
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    147116-67-4
  • Formula Weight
    468.67
  • Molecular Formula
    C32H40N2O
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:33.33 mg/mL (71.12 mM)
  • SMILES
    COc1ccc(cc1CN[C@H]1C2CCN(CC2)[C@H]1C(c1ccccc1)c1ccccc1)C(C)(C)C
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Hickman M A Cox S R Mahabir S et al. Safety pharmacokinetics and use of the novel NK‐1 receptor antagonist maropitant (Cerenia TM ) for the prevention of emesis and motion sickness in cats[J]. Journal of Veterinary Pharmacology and Therapeutics 2008 31(3):220-229.
molnova catalog
related products
  • QWF

    Tripeptide substance P (SP) antagonist (IC50 = 90 μM). Also inhibits binding of SP to Mas-related GPCR (MRGPR) X2. Inhibits SP-induced IgE-independent degranulation of mast cells in vitro. Inhibits compound 48/80-induced MRGPRX2 activation and scratching in mice in vivo.

  • Eledoisin

    Eledoisin is a specific agonist of NK2 and NK3 receptors.Eledoisin is an undecapeptide of mollusk origin, belonging to the tachykinin family of neuropeptides.Eledoisin increases the value recorded under basal conditions by 24.5±3.7%; this stimulation is significantly (P<0.01) lowered to 13.1±1.9% by the simultaneous presence of CP99994.

  • Fezolinetant

    A potent, selective, orally active neurokinin-3 receptor (NK3R) antagonist with pIC50/pKi of 7.7/7.6.